Marshall & Sterling Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$750K Buy
2,071
+177
+9% +$60.6K 0.44% 45
2026
Q1
$667K Sell
1,894
-359
-16% -$128K 0.44% 43
2025
Q4
$738K Sell
2,253
-2
-0.1% -$634 0.49% 40
2025
Q3
$633K Sell
2,255
-18
-0.8% -$5.22K 0.41% 45
2025
Q2
$631K Buy
2,273
+232
+11% +$65.7K 0.43% 42
2025
Q1
$636K Buy
2,041
+215
+12% +$63.5K 0.43% 41
2024
Q4
$476K Buy
+1,826
New +$542K 0.33% 58

Other funds holding AMGN

Marshall & Sterling Wealth Advisors's AMGN Position: Q2 2026 in Review

Marshall & Sterling Wealth Advisors increased its Amgen (AMGN) stake by 9.3% in Q2 2026, buying an estimated $60.6K and bringing the position to 2,071 shares worth $750K. The position accounts for 0.44% of the portfolio, ranked #45.

Marshall & Sterling Wealth Advisors first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 1,372 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Marshall & Sterling Wealth Advisors held 2,071 shares of Amgen worth $750K as of Q2 2026.
  • Marshall & Sterling Wealth Advisors bought 177 Amgen shares in Q2 2026, an estimated $60.6K.
  • Amgen made up 0.44% of Marshall & Sterling Wealth Advisors's portfolio in Q2 2026, its #45 holding.
  • Marshall & Sterling Wealth Advisors first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 1,372 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Marshall & Sterling Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.